Chuck Carelli

Chuck Carelli is Chief Financial Officer and Executive Partner at Flagship Pioneering. He joined Flagship in 2009 and, according to the firm, brings more than 25 years of financial management, operations, and transaction experience. His role covers fund and early-stage portfolio-company finance, legal aspects of operations, business structure management, financing, liquidity and M&A execution, investor engagement, reporting, tax, treasury, and compliance.

Before Flagship, Carelli spent 13 years at three NASDAQ-listed Massachusetts biotechnology companies. His most recent pre-Flagship role was CFO of Exact Sciences, and before that he held senior financial roles at Alkermes and Creative BioMolecules. He began his career as a CPA in Deloitte’s Boston office.

Carelli holds a B.A. in accounting from Assumption College. In November 2021, Flagship promoted him from CFO to CFO & Executive Partner, with CEO Noubar Afeyan noting that Carelli had played a role in “every fund raise, company raise, and every merger” during Flagship’s growth.

• Flagship’s model is not typical angel investing. The firm says it is the “principal founders, funders, and owners” of its companies and creates businesses internally through its Flagship Labs process.
• The firm starts with far-reaching “What if...?” explorations, runs about 80-100 explorations per year, originates 8-10 ProtoCos annually, and forms 6-8 NewCos annually when concepts validate.
• Flagship looks for proprietary platforms, not single-product startups: it says each NewCo focuses on a proprietary platform that can deliver years of important new products.
• Sector emphasis is first-in-category biology and life-science platforms that can transform human health or sustainability.
• Carelli’s investment relevance is finance, structuring, fundraising, liquidity, M&A, and investor engagement at the fund and early-stage portfolio-company levels rather than a publicly documented personal angel thesis.